Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 14, 2014; 20(6): 1493-1502
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1493
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1493
Current progress toward eradicating Helicobacter pylori in East Asian countries: Differences in the 2013 revised guidelines between China, Japan, and South Korea
Sun-Young Lee, Department of Internal Medicine, Konkuk University School of Medicine, Seoul 143-729, South Korea
Author contributions: Lee SY solely contributed to this paper.
Supported by Konkuk University
Correspondence to: Sun-Young Lee, MD, PhD, Department of Internal Medicine, Konkuk University School of Medicine. 4-12 Hwayang-dong, Gwangjin-gu, Seoul 143-729, South Korea. sunyoung@kuh.ac.kr
Telephone: +82-2-20307505 Fax: +82-2-20307505
Received: September 13, 2013
Revised: November 3, 2013
Accepted: January 6, 2014
Published online: February 14, 2014
Revised: November 3, 2013
Accepted: January 6, 2014
Published online: February 14, 2014
Core Tip
Core tip: Considerable advances in shifting from secondary prevention to primary prevention of gastric cancer are notable in the new 2013 guidelines from China, Japan, and South Korea. Compared to the previous guidelines, indications for Helicobacter pylori (H. pylori) eradication have expanded to include younger populations with acute gastric lesions, who will show markedly greater improvements than older populations with chronic gastric lesions. The indications of eradication, diagnostic methods, and treatment regimens for H. pylori infection differ between the countries due to differences in the approvals granted by the governments and national health insurance system in each country.